Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Gene Ther ; 19(4): 411-7, 2012 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-21850051

RESUMO

In liver cirrhosis, abnormal liver architecture impairs efficient transduction of hepatocytes with large viral vectors such as adenoviruses. Here we evaluated the ability of adeno-associated virus (AAV) vectors, small viral vectors, to transduce normal and cirrhotic rat livers. Using AAV serotype-1 (AAV1) encoding luciferase (AAV1Luc) we analyzed luciferase expression with a CCD camera. AAV1Luc was injected through the hepatic artery (intra-arterial (IA)), the portal vein (intra-portal (IP)), directly into the liver (intra-hepatic (IH)) or infused into the biliary tree (intra-biliar). We found that AAV1Luc allows long-term and constant luciferase expression in rat livers. Interestingly, IP administration leads to higher expression levels in healthy than in cirrhotic livers, whereas the opposite occurs when using IA injection. IH administration leads to similar transgene expression in cirrhotic and healthy rats, whereas intra-biliar infusion is the least effective route. After 70% partial hepatectomy, luciferase expression decreased in the regenerating liver, suggesting lack of efficient integration of AAV1 DNA into the host genome. AAV1Luc transduced mainly the liver but also the testes and spleen. Within the liver, transgene expression was found mainly in hepatocytes. Using a liver-specific promoter, transgene expression was detected in hepatocytes but not in other organs. Our results indicate that AAVs are convenient vectors for the treatment of liver cirrhosis.


Assuntos
Dependovirus/genética , Terapia Genética/métodos , Hepatócitos/metabolismo , Cirrose Hepática/terapia , Fígado/metabolismo , Transdução Genética , Animais , Vetores Genéticos , Artéria Hepática , Cirrose Hepática/genética , Regeneração Hepática/genética , Luciferases/genética , Luciferases/metabolismo , Masculino , Veia Porta , Ratos , Ratos Sprague-Dawley
2.
Gene Ther ; 14(3): 203-10, 2007 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-17024107

RESUMO

Liver transplantation is the only treatment for advanced liver cirrhosis. Therapies halting the progression of the disease are urgently needed. Administration of recombinant insulin-like growth factor-I (rIGF-I) induces hepatoprotective effects in experimental cirrhosis. Therefore, we analyzed the efficacy of a recombinant simian virus 40 vector (rSV40) encoding IGF-I (rSVIGF-I) to prevent cirrhosis progression. First, transgene expression was evaluated in mice injected with rSV40 encoding luciferase, which showed long-term hepatic expression of the transgene. Interestingly, luciferase expression increased significantly in CCl(4)-damaged livers and upon IGF-I administration, thus liver injury and IGF-I expression from rSVIGF-I should favor transgene expression. rSVIGF-I therapeutic efficacy was studied in rats where liver cirrhosis was induced by CCl(4) inhalation during 36 weeks. At the end of the study, the hepatic levels of IGF-I and IGF-binding protein 3 were higher in rSVIGF-I-treated rats than in control cirrhotic animals. Cirrhotic rats treated with rSVIGF-I had reduced serum bilirubin, transaminases and liver fibrosis scores and increased hepatic expression of hepatocyte growth factor and STAT3alpha as compared to cirrhotic animals. Furthermore, cirrhotic animals showed testis atrophy and altered spermatogenesis, whereas testicular size and histology were normal in cirrhotic rats that received rSVIGF-I. Therefore, rSV40-mediated sustained expression of IGF-I in the liver slowed cirrhosis progression.


Assuntos
Terapia Genética/métodos , Vetores Genéticos/administração & dosagem , Fator de Crescimento Insulin-Like I/genética , Cirrose Hepática Experimental/prevenção & controle , Fígado/metabolismo , Vírus 40 dos Símios/genética , Animais , Feminino , Expressão Gênica , Humanos , Injeções , Proteína 3 de Ligação a Fator de Crescimento Semelhante à Insulina/genética , Proteína 3 de Ligação a Fator de Crescimento Semelhante à Insulina/metabolismo , Fator de Crescimento Insulin-Like I/metabolismo , Fígado/patologia , Cirrose Hepática Experimental/metabolismo , Cirrose Hepática Experimental/patologia , Luciferases/genética , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Ratos , Ratos Wistar , Transdução Genética/métodos , Transgenes
3.
Curr Microbiol ; 53(6): 479-82, 2006 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-17091217

RESUMO

In the present study, the effect of acid stress on ammonium assimilation in Bradyrhizobium sp. SEMIA 6144 (Arachis hypogaea L.) microsymbiont was analyzed. The bacterial growth rate was decreased by 50%, and a significant increase in intracellular glutamate concentration was detected when the strain grew at acid pH (5.5). Assays of the enzymes involved in glutamate synthesis showed increased activities of glutamine synthetase (GS) and glutamate synthase (NADPH-GOGAT) under acid stress condition. This would support the contention that the GS/NADPH-GOGAT pathway contributes to the increase of glutamate synthesis as a compatible solute in response to acid stress.


Assuntos
Arachis/microbiologia , Bradyrhizobium/metabolismo , Ácido Glutâmico/metabolismo , Ácidos , Bradyrhizobium/crescimento & desenvolvimento , Glutamato Sintase (NADH)/metabolismo , Glutamato-Amônia Ligase/metabolismo , Concentração de Íons de Hidrogênio , Compostos de Amônio Quaternário/metabolismo , Transdução de Sinais , Simbiose
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...